These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2952685)

  • 1. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris.
    Leyden JJ; Shalita AR; Saatjian GD; Sefton J
    J Am Acad Dermatol; 1987 Apr; 16(4):822-7. PubMed ID: 2952685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR; Raimer S; Smith EB
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
    Schachner L; Pestana A; Kittles C
    J Am Acad Dermatol; 1990 Mar; 22(3):489-95. PubMed ID: 2138180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison.
    Shahlita AR; Smith EB; Bauer E
    Arch Dermatol; 1984 Mar; 120(3):351-5. PubMed ID: 6230999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris.
    Ellis CN; Gammon WR; Stone DZ; Heezen-Wehner JL
    Cutis; 1988 Sep; 42(3):245-7. PubMed ID: 2971512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin 2 percent gel in the treatment of acne vulgaris.
    Pochi PE; Bagatell FK; Ellis CN; Stoughton RB; Whitmore CG; Saatjian GD; Sefton J
    Cutis; 1988 Feb; 41(2):132-6. PubMed ID: 2964344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris.
    Katsambas A; Towarky AA; Stratigos J
    Br J Dermatol; 1987 Mar; 116(3):387-91. PubMed ID: 2952156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
    Kircik LH
    J Drugs Dermatol; 2017 Jun; 16(6):543-546. PubMed ID: 28686771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.
    Lookingbill DP; Chalker DK; Lindholm JS; Katz HI; Kempers SE; Huerter CJ; Swinehart JM; Schelling DJ; Klauda HC
    J Am Acad Dermatol; 1997 Oct; 37(4):590-5. PubMed ID: 9344199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
    Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
    Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clindamycin 1% solution versus clindamycin 1% gel in the treatment of acne vulgaris.
    Parker F
    Int J Dermatol; 1987 Mar; 26(2):121-2. PubMed ID: 2952611
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
    Kuhlman DS; Callen JP
    Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
    Cambazard F
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effectiveness of clindamycin phosphate (1% solution) compared with tetracycline (solution) administered topically in the treatment of acne vulgaris].
    Bran EL; Robledo Aguilar A
    Med Cutan Ibero Lat Am; 1986; 14(6):433-42. PubMed ID: 2951570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
    Amar L; Kircik LH
    J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris.
    Swinyer LJ; Baker MD; Swinyer TA; Mills OH
    Br J Dermatol; 1988 Nov; 119(5):615-22. PubMed ID: 2974719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
    Schmidt JB; Neumann R; Fanta D; Raab W
    Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.